Clinical Neurosciences Center
Welcome Howard Colman, MD, PhD
Neuro-Oncologist Joins Brain & Spine Tumor Program
SALT LAKE CITY – Howard Colman, MD, PhD has joined the University of Utah Department of Neurosurgery and Huntsman Cancer Institute in the Neurosciences Brain and Spine Tumor Center. Dr. Colman comes to Utah from MD Anderson Cancer Center at the University of Texas. He completed his medical education and PhD at Washington University School of Medicine in St Louis, Missouri. He trained in Neurology at Barnes-Jewish Hospital in St Louis, and Neuro-Oncology at MD Anderson Cancer Center in Houston.
Dr. Colman will see patients at the Clinical Neurosciences Center and Huntsman Cancer Hospital, providing care to patients with primary brain tumors and neurologic complications of cancer. His role will include overseeing chemotherapy for brain and spine tumors, coordinating surgical care and diagnosing patients with brain and spine tumors.
Dr. Colman’s research focuses on identifying molecular mechanisms and tumor stem cells that regulate tumor behavior and treatment resistance in brain tumors. By analyzing alterations in DNA copy number and gene expression in glioblastoma tumors, Dr Colman has identified specific molecular alterations that define tumor subtypes with different biological and clinical behavior. “What I am working on is identifying molecular predictors for therapy, which will allow us to personalize therapies to each patient’s specific condition,” says Dr Colman.
“Utah is lucky to have a neuro-oncologist of Dr Colman’s skill and caliber,” said William Couldwell, MD, PhD, Chair of the Department of Neurosurgery. “He brings excellence in clinical care and cutting-edge research to our patients.”